NOUVEAU COMPOSÉ AYANT UNE ACTIVITÉ INHIBITRICE DE BLT ET COMPOSITION POUR PRÉVENIR OU TRAITER DES MALADIES INFLAMMATOIRES, LE CONTENANT EN TANT QUE PRINCIPE ACTIF
Dongguk University Industry-Academic Cooperation Foundation;Korea University Research and Business Foundation
发明人:
申请号：
EP16830783.3
公开号：
EP3327000A1
申请日:
2016.07.23
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to a novel compound showing leukotriene B4 receptor 2 (BLT2) inhibitory activity and a pharmaceutical composition, for preventing or treating inflammatory diseases, comprising same as an active ingredient. The inventors identified a novel compound containing BTL2 inhibitory activity, and experimentally confirmed that the present novel compound had an excellent effect on the enhancement of the cancer cell death, on the inhibition of the metastasis and chemotactic mobility, and on the anti-asthma activity. Therefore, the present novel compound can be used as a very effective pharmaceutical component for treating the inflammatory-related diseases.
